MEDICAL MARIJUANA Scythian CEO on the potential impact of cannabinoid drugs on traumatic brain injuries April 5, 2020 Posted by cbdkingclub 05 Apr August 29, 2017 — Jonathan Gilbert, CEO and Director, and David Schrader, COO of Scythian Biosciences Corp. (TSXV: SCYB) (“Scythian”) in an interview with … source
